Clinical measures managed per guidelines between the identified hotspot locations and the surrounding areas
| Clinical measure | Within guidelines | ||
|---|---|---|---|
| Hotspot location | Rest of the sample | ||
| n=111 Count (%) | n=1072 Count (%) | p Value | |
| HbA1c | 67 (60.4) | 561 (52.3) | 0.11 |
| Cholesterol | 30 (27.0) | 261 (24.3) | 0.53 |
| LDL | 27 (24.3) | 225 (21.9) | 0.41 |
| Systolic | 49 (44.1) | 463 (45.1) | 0.85 |
| Diastolic | 65 (58.6) | 644 (62.7) | 0.76 |
| HDL | 54 (48.6) | 453 (44.1) | 0.70 |
| Triglycerides | 28 (25.2) | 416 (40.5) | 0.005* |
| BMI | 19 (17.1) | 163 (15.9) | 0.60 |
*p Value with a significance of ≤0.05.
BMI, body mass index; HbA1c, glycosylated haemoglobin; HDL, high-density lipid; LDL, low-density lipid.